Department of Orthopaedic Surgery, The University of Chicago, Chicago, Illinois.
J Bone Joint Surg Am. 2018 Jul 18;100(14):1171-1176. doi: 10.2106/JBJS.17.01414.
Prescription opioid use is epidemic in the U.S. Recently, an association was demonstrated between preoperative opioid use and increased health-care utilization following abdominal surgeries. Given that primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) are 2 of the most common surgical procedures in the U.S., we examined the association of preoperative opioid use with 30-day readmission and early revision rates.
We reviewed 2003 to 2014 data from 2 Truven Health MarketScan databases (commercial insurance and Medicare plus commercial supplemental insurance). Subjects were included if they had a Current Procedural Terminology (CPT) code for primary TKA or THA and were continuously enrolled in the database for at least 6 months prior to the index procedure. Preoperative opioid prescriptions were identified using National Drug Codes (NDCs). Rates of 30-day readmissions and revision arthroplasty were identified and compared among patients with stratified durations of preoperative opioid use in the 6 months preceding TKA or THA.
The study included 324,154 patients in the 1-year follow-up group and 159,822 patients in the 3-year follow-up group. Opioid-naive TKA patients had a lower revision rate than did those with >60 days of preoperative opioid use (1-year cohort: 1.07% compared with 2.14%, p < 0.001; 3-year cohort: 2.58% compared with 5.00%, p < 0.001). A similar trend was noted among THA patients (1-year: 0.38% compared with 1.10%, p < 0.001; 3-year: 1.24% compared with 2.99%, p < 0.001). These trends persisted after adjusting for age, sex, and Charlson Comorbidity Index (CCI). The 30-day readmission rate after TKA or THA was significantly lower for patients with no preoperative opioid use compared with those with >60 days of preoperative opioid use (TKA: 4.82% compared with 6.17%, p < 0.001; THA: 3.71% compared with 5.85%, p < 0.001). Again, this association persisted after adjusting for age, sex, and CCI.
Preoperative opioid use was associated with significantly increased risk of early revision and significantly increased risk of 30-day readmission after TKA and THA. This study illustrates the increased risk of poor outcomes and increased postoperative health-care utilization for patients with long-term opioid use prior to THA and TKA.
Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
处方类阿片药物在美国的使用呈流行趋势。最近,研究表明术前使用阿片类药物与腹部手术后的医疗保健利用率增加有关。鉴于初次全膝关节置换术(TKA)和全髋关节置换术(THA)是美国最常见的两种手术之一,我们研究了术前使用阿片类药物与 30 天再入院率和早期翻修率之间的关系。
我们回顾了 2003 年至 2014 年来自 2 个 Truven Health MarketScan 数据库(商业保险和医疗保险加商业补充保险)的数据。符合条件的患者包括接受初次 TKA 或 THA 的患者,并在索引手术前至少连续 6 个月在数据库中登记。术前阿片类药物处方通过国家药品代码(NDC)确定。在 TKA 或 THA 前 6 个月内,根据术前使用阿片类药物的时间长短,对接受分层的患者进行 30 天再入院和翻修关节成形术的发生率进行比较。
在 1 年随访组中,研究纳入了 324154 例患者,在 3 年随访组中,纳入了 159822 例患者。与术前使用阿片类药物超过 60 天的患者相比,阿片类药物未使用的 TKA 患者的翻修率较低(1 年队列:1.07%比 2.14%,p<0.001;3 年队列:2.58%比 5.00%,p<0.001)。THA 患者也有类似的趋势(1 年:0.38%比 1.10%,p<0.001;3 年:1.24%比 2.99%,p<0.001)。在调整年龄、性别和 Charlson 合并症指数(CCI)后,这些趋势仍然存在。与术前使用阿片类药物超过 60 天的患者相比,TKA 或 THA 后 30 天内再入院率显著降低(TKA:4.82%比 6.17%,p<0.001;THA:3.71%比 5.85%,p<0.001)。同样,在调整年龄、性别和 CCI 后,这种关联仍然存在。
术前使用阿片类药物与 TKA 和 THA 后早期翻修风险显著增加和 30 天再入院风险显著增加有关。这项研究表明,在接受 THA 和 TKA 之前长期使用阿片类药物的患者,其术后结局较差和术后医疗保健利用率增加的风险增加。
预后 IV 级。请参阅作者说明,以获取完整的证据水平描述。